MedPath

None

Brand Name: None

Generic Name: Leuprorelin Acetate

Active
Registration Number

DR-XY47450

Dosage Form

Lyophilized Powder For Injection (I.M./S.C.)

Issuance Date

October 11, 2021

Expiry Date

October 11, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength11.25mg
Packaging5 mL-capacity USP Type I clear and colorless single dose glass vial with gray butyl rubber stopper and aluminum seal with yellow-colored plastic flip-off cap + 2 mL (net content) USP Type I clear and colorless glass ampoule of sterile solvent (Box of 1 vial + 1 ampoule)

Classification

C
Classification
Prescription Drug (Rx)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Leuprorelin AcetateActive
Monograph: Leuprolide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform